Vincent J. Angotti
2020
In 2020, Vincent J. Angotti earned a total compensation of $1.8M as Chief Executive Officer at AcelRx Pharmaceuticals, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $284,533 |
|---|---|
| Option Awards | $489,049 |
| Salary | $636,540 |
| Stock Awards | $344,000 |
| Other | $11,400 |
| Total | $1,765,522 |
Angotti received $636.5K in salary, accounting for 36% of the total pay in 2020.
Angotti also received $284.5K in non-equity incentive plan, $489K in option awards, $344K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Vincent J. Angotti's compensation ranked 6,094th out of 13,090 executives tracked by ExecPay. In other words, Angotti earned more than 53.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,094 out of 13,090 | 53rd |
Division Manufacturing | 2,514 out of 5,624 | 55th |
Major group Chemicals And Allied Products | 1,009 out of 2,257 | 55th |
Industry group Drugs | 874 out of 1,957 | 55th |
Industry Pharmaceutical Preparations | 652 out of 1,462 | 55th |
Source: SEC filing on June 3, 2022.
Angotti's colleagues
We found two more compensation records of executives who worked with Vincent J. Angotti at AcelRx Pharmaceuticals in 2020.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019